Stay updated on ENLIVEN Trial Assessing BIO89-100 in NASH
Sign up to get notified when there's something new on the ENLIVEN Trial Assessing BIO89-100 in NASH page.

Latest updates to the ENLIVEN Trial Assessing BIO89-100 in NASH page
- Check3 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the usual content with an access-denied message, indicating a server or permission issue rather than a data update.SummaryDifference18%

- Check10 days agoChange DetectedThe page now shows Revision: v3.7.0 (instead of v3.6.6), reflecting a software release/version update. This change communicates a backend/UI update without altering study content or conclusions.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange Detected- Revision metadata updated from v3.6.5 to v3.6.6, reflecting a newer page version. This appears to be a backend/versioning update and does not modify study content or public-facing information.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, signaling a new build/version; this update appears to be an internal maintenance update rather than a change to study details or user-facing features.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, signaling a recent patch or update to the page. This change appears to modify only the revision tag and does not alter visible study details.SummaryDifference0.0%

- Check74 days agoChange DetectedThe keywords section replaces 'Fatty Liver Disease' with 'Steatotic Liver Disease' to reflect current terminology and improve search alignment.SummaryDifference0.1%

Stay in the know with updates to ENLIVEN Trial Assessing BIO89-100 in NASH
Enter your email address, and we'll notify you when there's something new on the ENLIVEN Trial Assessing BIO89-100 in NASH page.